Darryl Sleep on Collaboration and Partnership Across the Entire HHT Community: Patients Can’t Wait!
Darryl Sleep, Former Head Global Public Health at Amgen, BioPharma Executive, reposted from Azmi Nabulsi on LinkedIn:
”I am honored to be part of a dedicated team committed to developing focused, targeted therapeutics to address significant unmet medical need patients living with HHT.
The collaboration and partnership across the entire HHT community of researchers, academics, patient advocacy, patients and caregivers is truly inspiring.
All stakeholders work together with urgency and a deep commitment to improve the lives patients living with HHT.
Patients can’t wait!”
Quoting Azmi Nabulsi‘s post:
”It’s a proud moment for our team to see the engasertib data published in The New England Journal of Medicine.
This recognition validates the strength of the science, the rigor behind the work, and the potential impact for the HHT community.
Thank you to our team, our investigators, and the patients who made this possible.
We now move into the next phase with clarity and confidence as we advance toward our Phase 3 study in 2026.”
Stay updated with Hemostasis Today.
-
Jun 8, 2026, 06:30Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
-
Jun 8, 2026, 06:25Cécile Jefford: The NEHA Community and the Power of Human Connection
-
Jun 8, 2026, 06:02Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together